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Abstract 
Gastric  adenocarcinoma  developing  con-
comitantly  with  a  lymphoma  is  rare.
Furthermore,  B-cell  lymphoma,  originating
from  lymph  nodes,  with  eosinophilia  is
extremely rare. We report here a case with a
synchronous  diffuse  large  B-cell  lymphoma
(DLBCL) and an early adenocarcinoma of the
stomach. In addition, this case seemed to be
associated with paraneoplastic cutaneous vas-
culitis caused by hypereosinophilic syndrome
(HES)  with  mixed  cryoglobulinemia  (MC).
Many neoplastic diseases that affect internal
organs  display  cutaneous  manifestations,
which may be the presenting signs and symp-
toms of the underlying malignancy. In particu-
lar,  the  association  between  cutaneous  vas-
culitis  and  malignancy  has  been  widely
reviewed, and recently neoplasms have been
suggested to produce antigens and the result-
ant  immune  complex  formations,  activating
the serum complement, thus cause paraneo-
plastic  vasculitis.  In  this  case,  severe
eosinophilia  and  cryoglobulinemia  with  low
complements  were  observed  in  a  laboratory
test.  A  biopsy  specimen  from  a  skin  lesion
revealed leukocytoclastic vasculitis with severe
perivascular  infiltration  of  eosinophils.  The
cutaneous vasuculitis was considered to be a
manifestation of HES with MC, although there
were  no  etiological  factors  of  HES  and  MC.
Therefore, the vasculitis seems to be a symp-
tom of paraneoplastic syndrome in this case.
Our finding suggests that the potential pres-
ence of malignancies should be kept in mind
as a possible underlying disorder especially in
the presence of HES with MC; this possibility
is interesting also as regards at least part of
the pathogenesis for paraneplastic syndrome.  
Introduction 
Hypereosinophilic  syndrome  (HES)  is  a
clinical  disorder  characterized  by  persistent
eosinophilia and systemic signs, and the cuta-
neous lesions are one of the common manifes-
tations derived from HES, including vasculitis.
1
Although malignant T-cell lymphoma and other
malignant tumors associated with eosinophilia
have been reported sporadically,
1-3 B-cell lym-
phoma,  originating  from  lymph  nodes,  with
eosinophilia is extremely rare.
4,5 On the other
hand, cryoglobulinemia is defined as the pres-
ence of circulating immunoglobulins that pre-
cipitate with cold temperature. After immuno-
chemical typing, cryoglobulinemia is classified
as  type  I,  II,  and  III  cryoglobulinemia.
Furthermore,  type  II  and  III  are  defined  as
mixed cryoglobulinemia (MC), with a mono-
clonal component in type II and only polyclonal
immunoglobulins in type III. Since the discov-
ery of hepatitis-C virus (HCV) infection, it has
become clear that HCV is associated with most
cases of MC. In addition, MC is known to cause
a systemic vasculitis and, interestingly, it has
been  reported  that  patients  with  non-HCV
related  MC  vasculitis  have  a  four-fold
increased  risk  of  developing  B-cell  lym-
phomas.
6 These data suggest the presence of
MC itself is one of the risk factors for develop-
ing lymphomas. Furthermore, the association
between vasculitis and malignancy has been
widely reviewed, and recently neoplasms have
been suggested to be a causative factor of the
vasculitis.
7,8 Many reports regarding neoplastic
vasculitis have been published since, thus sug-
gesting  that  cutaneous  vasculitis  especially
may appear as an initiating sign of paraneo-
plastic syndrome.
9-12 We report here a female
patient  with  cutaneous  vasculitis  caused  by
HES and MC, subsequently diagnosed as syn-
chronous  diffuse  large  B-cell  lymphoma
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Figure 1. Skin lesions. (A) The gross appearance of purpura on the lower legs; (B, C) the
histological findings of the purpura, showing massive infiltration of neutrophils and lym-
phocytes with deposits of fibrin on the vessel wall. Marked eosinophil and red blood cell
infiltration is observed in the perivascular region. The cutaneous lesion was diagnosed as
leukocytoclastic vasculitis with severe perivascular eosinophil infiltration. (Hematoxylin-
eosin stain; magnification: B, 100X and C, 400X.)
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(DLBCL) and early gastric cancer. Our present
case  is  extremely  rare  and  it  suggests  the
requirement of surveillance of the cutaneous
vasculitis  for  the  underlying  malignancies
especially in the presence of HES with MC.
Case Report
A 63-year-old female visited our outpatient
department because of continuous fever, pur-
pura with pitting edema, and dysethesia in her
lower legs (Figure 1A) for a month. She was
admitted to our hospital for further examina-
tion.  A  biopsy  specimen  from  a  skin  lesion
revealed leukocytoclastic vasculitis with severe
perivascular infiltration of eosinophils (Figure
1B). Her laboratory findings on admission are
summarized in Table 1. These data revealed
significant hypereosinophilia (white blood cell
count [WBC], 7200 mm
3 with 52% eosinophils;
normal range: 1-5%), and elevated serum lev-
els  of  interleukin  (IL)-4  (7.4  pg/mL;  normal
range: <6 pg/mL) and IL-5 (59.3 pg/mL; normal
range:  <10  pg/mL),  which  are  known  to  be
growth factors for eosinophils. Neither atypical
lymphocytes nor lymphoblastic cells were rec-
ognized.  The  C-reactive  protein  (CRP)  level
was  0.8  mg/dL  (normal  range:  <0.3  mg/dL),
thus indicating a weak inflammatory reaction.
Both titers of myeloperoxidase anti-neutrophil
cytoplasmic  antibody  (MPO-ANCA)  and  pro-
teinase-3  (PR3)-ANCA  were  negative.  The
serum  level  of  rheumatoid  factor  (RF)  was
strongly  positive  (751  IU/mL;  normal  range:
<20 IU/mL) although no clinical symptoms of
rheumatoid arthritis (such as tenderness or
swollen  joints)  were  observed,  and  antinu-
clear-antibody (ANA) titers and disease-specif-
ic antinuclear antibodies were negative (40X;
normal range: <80X). She also demonstrated
some  abnormal  findings  such  as  cryoglobu-
linemia or decreased serum complement lev-
els, especially the C4 component (<3 mg/dL;
normal  range:  13-35  mg/dL).  Several  days
before admission, she progressively developed
systemic peripheral lymphadenopathy (medi-
astinal, axillar, and inguinal), and her labora-
tory tests revealed an elevated serum level of
soluble IL-2 receptor (sIL-2R). FIP1L1-PDGFRA
mutation was not observed. MC is known to
cause leukocytoclastic vasculitis owing to the
deposition of immune complexes on the vessel
wall and the activation of complements result-
ing in vascular damage. Therefore, we consid-
ered the cutaneous vasculitis to be a manifes-
tation of HES with MC because of the presence
of severe eosinophila and perivascular infiltra-
tion  by  eosinophils.  Regarding  the  lym-
phadenopathy and elevated serum level of sIL-
2R, we suspected the presence of malignant
lymphoma  or  other  hematological  malignan-
cies;  thus,  a  biopsy  was  performed  on  the
inguinal lymph node. The lymph node speci-
men showed an accumulation of CD20-positive
B-cells  on  immunohistochemical  staining
(Figure  2A).  Initially  the  patient  was  diag-
nosed with follicular lymphoma because BCL2
staining  was  positive  (Figure  2B);  however,
hematoxylin and eosin (HE) staining (Figure
2C) and BCL2 staining revealed that the follic-
ular formation was not so obvious and diffuse
proliferation of the cells was recognized con-
comitantly.  Subsequent  CD10  staining  was
negative and genetic transformation t(14;18)
was not observed (data not shown). CD10 and
t(14;18) are generally highly positive in follic-
ular  lymphoma;  therefore,  the  patient  was
diagnosed ultimately with DLBCL transformed
from follicular B-cell lymphoma. To exclude the
possibility of other types of B-cell lymphomas
Case Report
Figure 2. Biopsy specimens from lymph node (A-C) and stomach (D-E), showing anti-
CD20 antibody immunohistochemical staining (A) and anti-BCL2 antibody immunohis-
tochemical staining of the lymph node specimen (B), magnification: 40X; hematoxylin-
eosin  staining  of  the  lymph  node  specimen  (C),  magnification:  12.5X;  and  (D)  the
macroscopic finding of a biopsy specimen from the gastric lesion (indicated by arrow),
and (E) hematoxylin-eosin staining, magnification: 10X. The specimen from the lymph
node was strongly positive for CD20 and BCL2. Hematoxylin-eosin and BCL-2 staining
showed some follicular formations and diffuse proliferation of the cells concomitantly.
The patient was diagnosed with DLBCL transformed from follicular B-cell lymphoma.
The gastroscopy specimen revealed irregular atypical cell proliferation in the mucosa, and
the patient was diagnosed with early gastric cancer (tubular adenocarcinoma). 
Figure 3. A schematic figure illustrating the hypothesis for paraneoplastic vasculitis with
hypereosinophilic syndrome and mixed cryoglobulinemia. IC: immune complexes, APC:
antigen-presenting cells, T: T-lymphocytes, B: B-lymphocytes, Eo: eosinophilia, MC:
mixed cryoglobulinemia, HES: hypereosinophilic syndrome. 
A
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such  as  mucosa-associated  lymphoid  tissue
(MALT)  lymphoma,  mantle  cell  lymphoma,
Burkitt lymphoma, and small lymphocytic lym-
phoma,  a  gastroscopy  was  performed  and  it
revealed a protruding lesion with ulceration at
the lesser curvature in the corpus ventriculi
(Figure 2D, left). Unexpectedly, the histologi-
cal findings indicated an early stage of gastric
cancer (Figure 2D, right) and the histological
diagnosis was a gastric cancer, IIc, tubular ade-
nocarcinoma (tub1), m, ly0, v0, cut margin(-),
although there was no evidence of lymphoma.
As  a  result,  the  patient  was  diagnosed  with
cutaneous leukocytoclastic vasculitis with syn-
chronized occurrence consisting of DLBCL and
early gastric adenocarcinoma. An endoscopic
mucosal resection was performed as a treat-
ment for her gastric cancer, and thereafter she
underwent chemotherapy for the lymphoma in
the hematological department of our hospital.
The  treatment  for  DLBCL  was  successfully
accomplished using chemotherapy with a THP-
COP  regimen  comprising  cyclophosphamide,
pirarubicin  (tetrahydropyranyl  adriamycin
[THP]),  vincristine,  and  prednisolone.  The
symptoms related to the cutaneous leukocyto-
clastic vasculitis disappeared totally.  
Discussion 
It is extremely rare that HES occurs not in B-
cell  but  in  T-cell  lymphomas,  and  that  lym-
phoma  and  gastric  adenocarcinoma  occur
simultaneously.  In  a  MEDLINE  literature
search (keywords: gastric cancer, B-cell lym-
phoma, and vasculitis), no item was found. We
believe that this is the first report of synchro-
nous  malignant  B-cell  lymphoma  and  early
gastric cancer associated with paraneoplastic
vasculitis caused by HES with MC. In addition,
it appears clinically important for us to recog-
nize  cutaneous  vasculitis  as  paraneoplastic
syndrome. In this report, we discuss the etiolo-
gy of paraneoplastic vasculitis.
The relative risk of the occurrence of solid
tumors  and  hematological  malignancies  is
known to be higher in autoimmune patients
than  in  the  normal  population,  and  some
autoimmune disorders can appear to be para-
neoplastic syndrome before a malignant tumor
is identified.
13 Several reports have indicated
that vasculitis can be a paraneoplastic symp-
tom in either hematological malignancies or
solid tumors.
14-16 Vasculitis is an inflammatory
condition that can affect any type of blood ves-
sel  owing  to  several  immunologic  mecha-
nisms. The possible mechanisms of paraneo-
plastic vasculitis include invasion of circulat-
ing tumor cells toward the vessel wall, damage
to the endothelium by cytokines released from
circulating tumor cells, the cross-reaction with
autoantibodies that can bind either tumor-spe-
cific antigens or endothelial antigens, and the
deposition of circulating immune complexes,
resulting in tissue damage because of comple-
ment-mediated cell destruction. The presence
of cryoglobulin and low plasma C4 levels in our
patient also indicate that circulating immune
complexes may play an important role in the
induction of the vasculitis. Interestingly, it has
been reported that MC itself is a risk factor for
lymphoma  development.
16 Although  MC  is
known to be observed frequently in patients
with  HCV  infections,  our  patient  did  not
demonstrate  any  antibodies  or  antigens  for
HCVs. In a case of non-HCV related MC, we
should pay more attention to lymphocytic dis-
orders or malignant tumors, which are under-
lying MC as reported previously.
6 Furthermore,
it  has  been  reported  that  hypocomple-
mentemia is associated with lymphoma devel-
opment in primary Sjogren’s syndrome.
17 Our
case  is  able  to  support  these  notions.
Regarding another etiology of paraneoplastic
vasculitis, tumor antigens may activate lym-
phocytes, thus resulting in an over-production
of T-helper (TH)-2 type cytokines, such as IL-4
or  IL-5,  and  subsequently  recruiting
eosinophils to the vessels; these phenomena
seem to have contributed to the development
of HES. In fact, higher expressions of these
cytokine  proteins  in  certain  lymphoma  cells
have been reported.
16 HES is defined by three
diagnostic  criteria:  eosinophils,  >1.5x10
9/L,
persistent eosinophilia and/or organ damage
or  dysfunction,  and  exclusion  of  secondary
causes of eosinophilia such as parasite infec-
tion or allergic reaction. HES is classified fur-
ther  as  myeloproliferative  HES,  lymphocytic
HES,  familial  HES,  associated  HES,  overlap
HES, and undefined HES.
18Identification of the
lymphocytic HES rests on recognition of the
helper T-cell subset (especially TH2) and clon-
al overgrowth of specific cytokine (especially
IL-5) producing cells. Although we did not con-
firm the T-cell clonality producing IL-5, B-cell
abnormality derived from DLBCL may stimu-
late the T-cell clones resulting in HES. 
Literature analyses indicate that character-
istics of representative paraneoplastic vasculi-
tis show cutaneous leukocytoclastic vasculitis
or  cryoglobulinemic  vasculitis.  Recently,
Solans-Laque et al. reported that the most com-
mon vasculitis in solid tumors was leukocyto-
clastic vasculitis and the most common malig-
nancies were in urinary organs, gastrointesti-
nal tract, and lung.
19 Furthermore, they men-
tioned that 13 of 15 patients demonstrated con-
cordance  of  disease  activity  and  treatment
response for cancer and vasculitis, apart from
46.6% cases of the vasculitis that flared up,
heralding  tumor  recurrence  or  progression.
They  suggested  that  resolution  of  vasculitis
following effective treatment of the putatively
linked malignancy, and recurrence of vasculi-
tis heralding tumor recurrence or progression,
provide strong evidence for vasculitis being a
true  paraneoplastic  syndrome,  not  occurring
Case Report
Table 1. Laboratory findings on admission.
WBC 7900/mL AST 15 IU/L RF 751 IU/mL
Neutro 27.0% ALT 6 IU/L ANA 40X
Lympho 13.0% ALP 362 IU/L αDNA Ab (-)
Mono 5.0% LDH 271 IU/L αRNP Ab (-)
Eosino 52.0% CPK 61 IU/lL  αSm Ab (-)
AtyLy (-) BUN 11 mg/dL αSS-A Ab (-)
Blast (-) Crea 0.6 mg/dL αSS-B Ab (-)
RBC 382x10
4/mL UA 3.1 mg/dL αCL‚2GP1 Ab (-)
Hb 12.4 g/dL TP 5.9 g/dL PR3-ANCA (-)
Ht 35.7% ALB 3.8 g/dL MPO-ANCA (-)
Plt 16.1 x  IgG 874 mg/dL Cryogloblin (+)
CRP 10
4/mL IgA 178 mg/dL MMP-3 41.7  ng/mL
ESR 0.8 mg/dL IgM 170 mg/dL HCV (-)
PT-INR 5 mm/h IgE 43.0 mg/dL HBV (-)
APTT 1.18 CH50 <5 U/mL sIL-2R 2610 U/mL
Ferritin 33.4 sec C3 70 U/mL  IL-4 7.3 pg/mL
191.4 ng/mL C4 <3 U/mL IL-5 59.3 pg/mL
Urinalysis CEA 0.9 U/mL ECP 2.7 μg/lL
Blood (-) CA19-9 1.9 U/mL
Protein (-)  FIP1L1-  mutation (-)
Glucose (-) PDGFRA[Rare Tumors 2009; 1:e42] [page 131]
by chance.
19 Skin purpura or papules appear to
be  the  most  common  skin  manifestations,
while  hematological  malignancies  such  as
lymphoma are the most common malignancies
presenting as underlying diseases.
9-12 Our case
supports these notions and reminds us that we
should pay attention to the importance of per-
forming  careful  examinations  in  order  to
exclude  other  diseases,  especially  malignan-
cies  that  may  exist  as  underlying  causes  of
HES  and  MC,  with  skin  involvement  as  an
important sign of paraneoplastic syndrome.
Finally, our hypothesis regarding the patho-
genesis of the paraneoplastic vasculitis in the
present case is shown in Figure 3. We think
two possible mechanisms for the paraneoplas-
tic vasculitis derived from gastric cancer and
lymphoma are considerable. In gastric carcino-
ma, tumor antigens of gastric cancer may be
released into the extracellular region and rec-
ognized by the immune system as autoanti-
gens in a particular individual, resulting in an
immune  activation  against  the  tumor  anti-
gens. Once the immune system is activated,
anti-tumor-antigen  antibodies  are  produced;
furthermore,  aberrant  cytokine  production
may be induced. The antibodies possibly react
with  vessel  wall  antigens  by  cross-reaction,
resulting in the formation of immune complex-
es  on  the  vessel  wall.  Then,  complement  is
recruited to the immune complexes and acti-
vated,  ultimately  resulting  in  the  vasculitis.
The aberrant cytokine production, such as IL-4
and IL-5, can promote eosinophilic prolifera-
tion  and  activation  resulting  in  HES.  The
eosinophilic  infiltration  in  the  perivascular
region may exacerbate the symptoms of the
vasulitis further. In lymphomas, the B-cell lym-
phomas may induce abnormal activation of the
lymphocytes resulting in autoantibody produc-
tion, such as cryoglobulin or anti-vascular cells
autoantibody.  The  aberrant  activation  of  the
lymphocytes  also  may  induce  excessive  IL-4
and IL-5 production. The autoantibodies may
interact with the vessel wall resulting in the
vasculitis as described previously. In the pres-
ent case, the latter appeared to be the main
factor of the vasculitis rather than the former,
because the gastric cancer is at the early stage,
and it is difficult to think that small early gas-
tric cancers cause the paraneoplastic phenom-
enon. 
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